The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 373.50
Bid: 371.50
Ask: 372.50
Change: 6.00 (1.63%)
Spread: 1.00 (0.269%)
Open: 367.00
High: 374.50
Low: 366.00
Prev. Close: 367.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Breedon may face site sales in three areas

6 Feb 2014 07:00

RNS Number : 4035Z
Competition Commission
06 February 2014
 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

News Release

 

04/14 6 February 2014

Breedon may face site sales in three areas

Breedon Aggregates Limited (Breedon) may have to sell asphalt and ready-mix concrete (RMX) operations in three areas of north-east Scotland after the Competition Commission (CC) provisionally found that some customers could face higher prices following Breedon's acquisition of a package of assets from Aggregate Industries UK Limited (Aggregate Industries).

Breedon completed the acquisition in April 2013, which included 11 aggregate quarries, four asphalt plants, nine RMX plants and two concrete block factories, located at 18 sites in north Scotland. Prior to the acquisition Breedon was the largest supplier of these products in north-east Scotland.

In a summary of its provisional findings published today, the CC states that Breedon and Aggregate Industries were previously competitors for many of these products across north-east Scotland and that asphalt customers in Aberdeen and Inverness as well as RMX customers in Peterhead, could face higher prices due to the loss of competition and lack of alternative suppliers.

The CC has also today published a Notice of possible remedies to address the anticompetitive effects of the merger, which include requiring Breedon to sell asphalt and RMX operations in the areas concerned to a competitor approved by the CC.

Simon Polito, Chairman of the Inquiry Group and CC Deputy Chairman, said:

'The nature of these products means the markets are local-they are expensive to transport and additionally RMX has a short shelf life. So the loss of a competitor in even a relatively small area matters when the cost and proximity of the production site are the most important factors for customers and in a market where most prices are negotiated. Both products are also vital for construction projects and road building. We now want to look in detail at what measures will protect the interests of customers. This is likely to involve the sale of asphalt and RMX sites in the affected areas.'

The CC is required to publish its final report by 5 May 2014.

Any interested party is invited to respond to the provisional findings report, in writing, by no later than 27 February 2014. The full provisional findings report will be published shortly. To submit evidence, please email Breedon-AI@cc.gsi.gov.uk or write to:

Inquiry Manager

Breedon/AI merger inquiry

Competition Commission

Victoria House

Southampton Row

LONDON

WC1B 4AD

Notes for editors

1. The CC is an independent public body, which carries out investigations into mergers, markets and the regulated industries. In April, the CC will join with the competition and certain consumer functions of the Office of Fair Trading (OFT) to form the new Competition and Markets Authority.

2. The members of the Inquiry Group are: Simon Polito (Chairman of the Group), Robin AaronsonLesley Ainsworth and Graham Sharp.

3. The Enterprise Act 2002 empowers the OFT to refer to the CC completed or anticipated mergers for investigation and report which create or enhance a 25 per cent share of supply in the UK (or a substantial part thereof) or where the UK turnover associated with the enterprise being acquired is over £70 million.

4. The CC has a 24-week period in which it is required to publish its report, which may be extended by no more than eight weeks if it considers that there are special reasons why the report cannot be published within that period. On 4 February 2014, the CC extended the reference period by eight weeks to 5 May 2014 due to the late provision of new market data that has delayed the publication of its provisional findings.

5. Further information on this inquiry, including the terms of reference and other key documents, as well as on the CC and its procedures, including its policy on the provision of information and the disclosure of evidence, can be obtained from the CC website at: www.competition-commission.org.uk.

6. Enquiries should be directed to Rory Taylor or Siobhan Allen or by ringing 020 7271 0242.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STCQKPDPABKDDBK
Date   Source Headline
2nd May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20243:06 pmRNSTotal Voting Rights
26th Apr 20243:39 pmRNSDirector/PDMR Shareholding
24th Apr 20244:40 pmRNSResult of AGM
24th Apr 20243:33 pmRNSDirector/PDMR Shareholding
24th Apr 20247:00 amRNSAGM Trading Update
5th Apr 20243:49 pmRNSDirector/PDMR Shareholding
4th Apr 20242:35 pmRNSDirector/PDMR Shareholding
28th Mar 20244:11 pmRNSTotal Voting Rights
18th Mar 202410:00 amRNS2023 Annual Report and Notice of AGM
12th Mar 20243:09 pmRNSApplication for Admission of Consideration Shares
7th Mar 20247:00 amRNSCompletion of Acquisition
6th Mar 20247:00 amRNSAcquisition
6th Mar 20247:00 amRNSFinal Results
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20243:51 pmRNSHolding(s) in Company
5th Feb 202410:00 amRNSNotice of Results
31st Jan 20249:18 amRNSTotal Voting Rights
29th Jan 20244:09 pmRNSHolding(s) in Company
29th Dec 20237:00 amRNSBlock listing six monthly return
29th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSNovember Trading Statement
16th Nov 202310:07 amRNSDirector/PDMR Shareholding
8th Nov 20234:01 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
19th Oct 20231:59 pmRNSHolding(s) in Company
9th Oct 20232:24 pmRNSHolding(s) in Company
9th Oct 20232:23 pmRNSDirector/PDMR Shareholding
9th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 202310:53 amRNSDirector/PDMR Shareholding
9th Oct 202310:47 amRNSHolding(s) in Company
6th Oct 20235:15 pmRNSDirector/PDMR Shareholding
5th Oct 20235:32 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSIntention to acquire additional shares of Breedon
3rd Oct 20237:00 amRNSInvestor site visit
2nd Oct 202311:18 amRNSInterim Dividend Timetable
29th Sep 20239:37 amRNSTotal Voting Rights
31st Aug 202310:15 amRNSTotal Voting Rights
30th Aug 20235:02 pmRNSDirector/PDMR Shareholding
31st Jul 202311:36 amRNSTotal Voting Rights
26th Jul 20237:00 amRNSInterim results 2023
3rd Jul 20231:55 pmRNSNotice of Interim Results 2023
30th Jun 20239:55 amRNSTotal Voting Rights
27th Jun 202311:48 amRNSBlock Listing of Ordinary Shares
13th Jun 202310:51 amRNSReduction of Capital Effective
6th Jun 20235:02 pmRNSOutcome of Court Hearing on Reduction of Capital
2nd Jun 20233:25 pmRNSHolding(s) in Company
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.